Bonus BioGroup Ltd. Logo

Bonus BioGroup Ltd.

A clinical-stage biotech firm developing cell therapy and tissue engineering products.

BONS | TA

Overview

Corporate Details

ISIN(s):
IL0004850116
LEI:
Country:
Israel
Address:
Park P.O.B 15143, 31905 Haifa

Description

Bonus BioGroup Ltd. is a clinical-stage biotechnology company that develops cell therapy and tissue engineering products. The company's research focuses on addressing unmet medical needs related to tissue damage, inflammation, and immune response. Its core technology platforms include an investigational cell therapy designed to modulate inflammation and promote tissue repair using mesenchymal cells, and a viable tissue engineering approach that combines patient-derived cells with biomaterials for bone regeneration. Key product candidates in its pipeline are BonoFill, a personalized, tissue-engineered bone graft for orthopedic and maxillofacial defects, and MesenCure, an allogeneic cell therapy developed to target inflammation and tissue damage. These investigational therapies are currently being evaluated in clinical trials for safety and efficacy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-27 11:48
Company Presentation- 2025
Hebrew (modern) 9.0 MB
2025-05-27 11:48
Company Presentation- 2025
Russian 43.6 KB
2023-07-11 12:06
Company Presentation, July 2023
English 3.4 MB
2023-07-11 12:06
Company Presentation, July 2023
Russian 44.7 KB
2022-04-11 16:02
Company Presentation
English 8.2 MB
2022-04-11 16:02
Company Presentation
Russian 47.1 KB
2022-04-11 15:01
Company Presentation
Hebrew (modern) 11.0 MB
2022-04-11 15:01
Company Presentation
Russian 47.1 KB
2022-01-10 10:52
The company inteds to publish an immediate report, trading will be open after …
Hebrew (modern) 105.1 KB

Automate Your Workflow. Get a real-time feed of all Bonus BioGroup Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bonus BioGroup Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bonus BioGroup Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Human Stem Cells Institute PJSC Logo
Develops gene therapies, vaccines, medical devices, and genetic testing systems.
Russian Federation
ISKJ
HVIVO PLC Logo
A contract research organization specializing in human challenge trials for biopharma.
United Kingdom
HVO
Hybrigenics SA Logo
Provider of technologies for studying molecular interactions and antibody selection.
France
ALHYG
A contract research organization providing clinical trial services with a focus on oncology.
South Korea
187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Develops antiviral and anticancer drugs using a proprietary drug delivery system.
South Korea
048410
ICON PLC Logo
Global provider of outsourced development services for pharma, biotech & medical device.
United States of America
ICLR
IGC Pharma, Inc. Logo
Clinical-stage biotech firm developing AI-driven treatments for Alzheimer's disease.
United States of America
IGC
IMCB PJSC Logo
Biotechnology company specializing in personal stem cell banking and genetic testing.
Russian Federation
GEMA
Immuneering Corp Logo
Clinical-stage oncology company developing medicines using computational technology.
United States of America
IMRX
IMMUNIC, INC. Logo
Develops oral small molecule therapies for chronic inflammatory and autoimmune diseases.
United States of America
IMUX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.